Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function
Immunity · 2025
DOI: 10.1016/j.immuni.2025.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Can Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Integrin alpha Chains, Antigens, CD, Immunologic Memory, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, National Institutes of Health National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Integrin CD103 binds to E-cadherin, a cell adhesion molecule predominantly expressed on epithelial cells, thus mediating the tissue residency of CD103+ T cells in barrier sites. Importantly, circulating naive CD8+ T cells also express large amounts of CD103, but whether CD103 contributes to CD8+ T cell immunity beyond its role in cell adhesion is unclear. Here, we report that CD103 expression in naive CD8+ T cells facilitates their engagement with E-cadherin-expressing cells, promoting their acquisition of memory phenotype and effector function. Notably, dendritic cell (DC) subsets expressing E-cadherin and producing type I interferons and interleukin-12 (IL-12) were responsible for this process. As a corollary, the DC-specific loss of E-cadherin resulted in diminished effector CD8+ T cell differentiation and increased tumor susceptibility, while the forced expression of CD103 enhanced the effector functions and anti-tumor activity of CD8+ T cells, revealing a regulatory role for CD103 in cytotoxic T cell immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Surgery, Guthrie Robert Packer Hospital, Sayre, PA 18840, USA.
- Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Oral and Maxillofacial Surgery, Seoul National University School of Dentistry, 101 Daehakn…
- Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: parkhy@mail.nih.gov.
Förderung
- Intramural NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- Center for Cancer Research
- U.S. Department of Health and Human Services
Zitieren
APA
Li, C., Ligons, D. L., Lanasa, D., Keller, H. R., Luckey, M. A., Capaldo, B., Meerzaman, D., Park, J. Y., & Park, J. H. (2025). Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function. Immunity. https://doi.org/10.1016/j.immuni.2025.08.014
Vancouver
Li C, Ligons DL, Lanasa D, Keller HR, Luckey MA, Capaldo B, et al. Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function. Immunity. 2025. doi:10.1016/j.immuni.2025.08.014
BibTeX
@article{Li2025,
author = {Li, Can and Ligons, Davinna L and Lanasa, Dominic and Keller, Hilary R and Luckey, Megan A and Capaldo, Brian and Meerzaman, Daoud and Park, Joo-Young and Park, Jung-Hyun},
title = {Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function},
journal = {Immunity},
year = {2025},
doi = {10.1016/j.immuni.2025.08.014}
}
EUVIMED